Apellis Pharmaceuticals, Inc. | NASDAQ:APLS - Fraywire Market Portal
⚡ Login to use Pulse AI
Simple Chart
Advanced Chart
Login for Volatility Chart


Apellis Pharmaceuticals, Inc. on Glideslope

News aggregated by Glideslope.ai
July 29, 2025
(RTTNews) - Apellis Pharmaceuticals Inc. (APLS) announced that the U.S. Food and Drug Administration has approved EMPAVELI (pegcetacoplan) as...